Vasoactive Intestinal Peptide is a neuropeptide studied for its anti-inflammatory and immune/neuro signalling roles.
Vasoactive Intestinal Peptide (VIP) is a 28-amino-acid neuropeptide widely researched for its role in intercellular signalling across the nervous, immune, and vascular systems. In laboratory and animal models it has been studied in the context of anti-inflammatory pathways, vasodilation, and modulation of immune cell activity. Researchers examine VIP for how it engages receptor-mediated cyclic-AMP signalling.
Investigations often focus on VIP's interaction with VPAC receptors and its effects on cytokine profiles in preclinical settings. It remains a subject of interest in neuro-immunology research.
Studied for modulation of immune cell activity and cytokine balance in models.
Researched in the context of anti-inflammatory receptor-mediated signalling.
Examined as a neuropeptide influencing neural and circadian signalling.
Investigated for vasodilatory effects on smooth muscle in preclinical work.
Bring the vial (10 mg) and bacteriostatic water to room temperature.
Add bacteriostatic water slowly along the glass wall — the volume you add sets the concentration.
Swirl gently (do not shake) until fully clear, then refrigerate at 2–8 °C.
Explored alongside recovery peptides in tissue-signalling research contexts.
Links open a PubMed search for the topic. They point to independent literature and are provided for orientation in a research context only.
It is researched for anti-inflammatory, immune, and neuropeptide signalling roles in laboratory and animal models.
Studies describe engagement of VPAC receptors and downstream cyclic-AMP pathways.
No. VIP is a research peptide intended for laboratory research only, not human use.
You must be at least 21 years old to enter this website.
By clicking "Confirm & Enter", you confirm that you are 21 years of age or older and understand that all products sold on this website are intended for research purposes only.
